Ejner Bech Jensen

Title: Ejner Bech Jensen: Innovator in Antimicrobial Peptides and Heme Proteins

Introduction

Ejner Bech Jensen is a notable inventor based in Virum, Denmark. He has made significant contributions to the field of biotechnology, particularly in the production of antimicrobial peptides and heme proteins. With a total of 6 patents to his name, Jensen's work has implications for both animal feed and pharmaceutical applications.

Latest Patents

One of Jensen's latest patents focuses on the recombinant production of antimicrobial peptides. This invention relates to the co-expression of an antimicrobial agent and an enzyme to improve yield and overall production economy. The antimicrobial agents include peptides such as lactoferricins, while the enzymes range from endoglucanase to alpha-amylase. A novel fusion product comprising the antimicrobial agent and the enzyme, along with a cleavable linker, can be utilized in animal feed and additives. Additionally, the invention describes a protection domain that temporarily inactivates the antimicrobial peptide during expression, enhancing its utility.

Another significant patent involves a process for producing heterologous heme proteins. This method includes transforming a filamentous fungus with a vector that encodes the heme protein and a preregion for secretion. The transformed fungus is then cultured in a suitable medium to produce the desired heme protein.

Career Highlights

Jensen has worked with prominent companies in the biotechnology sector, including Novo Nordisk A/S and Novozymes Pharma Biotec A/S. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative work.

Collaborations

Throughout his career, Jensen has collaborated with notable colleagues such as Henrik Dalbo Slashedge and Karen Gjesing Welinder. These partnerships have likely enriched his research and development efforts.

Conclusion

Ejner Bech Jensen's contributions to biotechnology, particularly in antimicrobial peptides and heme proteins, showcase his innovative spirit and dedication to advancing the field. His patents reflect a commitment to improving production processes and enhancing the efficacy of biological agents.